Nanjing Bioheng Biotech Co., Ltd.
Clinical trials sponsored by Nanjing Bioheng Biotech Co., Ltd., explained in plain language.
-
Scientists test One-Shot cell therapy to reset the immune system in autoimmune patients
Disease control Recruiting nowThis early-stage study is testing a new type of cell therapy called RD06-05 for people with active autoimmune diseases. The therapy involves modifying a patient's own immune cells (CAR-T cells) to target and remove harmful immune cells, aiming to reset the immune system. The main…
Phase: EARLY_PHASE1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Scientists test One-Time cell therapy to reset the immune system in devastating autoimmune conditions
Disease control Recruiting nowThis early-stage study is testing a new, one-time cell therapy called RD06-05 for people with serious autoimmune diseases like lupus and vasculitis. The therapy, known as CAR-T, involves modifying a patient's own immune cells to target and remove the harmful cells causing the dis…
Phase: EARLY_PHASE1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Cancer-Fighting cell therapy tested against lupus and other autoimmune diseases
Disease control Recruiting nowThis early-stage study is testing whether a type of cell therapy called CAR-T, which is used to treat some cancers, can help people with serious autoimmune diseases like lupus, scleroderma, and vasculitis. The therapy involves collecting a patient's own immune cells, modifying th…
Phase: EARLY_PHASE1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC